HERON THERAPEUTICS, INC. /DE/ (HRTX)
About HERON THERAPEUTICS, INC. /DE/
Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Net income
- -$20.2M
- Total assets
- $255.9M
- Market cap
- $80.9M
- Gross margin
- 73.3%
- Operating margin
- -1.6%
- Net margin
- -13.0%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $154.9M
- Cost of revenue
- $41.3M
- Gross profit
- $113.6M
- Operating expenses
- $116.1M
- Operating income
- -$2.5M
- Income tax
- $0
- Net income
- -$20.2M
- EPS (basic)
- $-0.12
- EPS (diluted)
- $-0.12
Balance sheet
- Total assets
- $255.9M
- Current assets
- $238.1M
- Total liabilities
- $241.5M
- Current liabilities
- $96.1M
- Shareholders’ equity
- $14.3M
Cash flow
- Operating cash flow
- -$27.6M
- Investing cash flow
- $16.0M
- Financing cash flow
- $14.4M
- Net cash flow
- $2.8M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $80.9M
- EPS (diluted)
- $-0.12
- Shares outstanding
- 175.9M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Aug 27, 1987
Heron Therapeutics, Inc. /DE/ (HRTX) Stock Price
- Reported a net loss of $20.2M.
- Revenue grew 79% from FY2021 to FY2025.
- Gross margin of 73.3%, net margin -13.0%.
- Trading 79% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review HERON THERAPEUTICS, INC. /DE/.
Write a review
News about HERON THERAPEUTICS, INC. /DE/
News & sentiment via Polygon.io
Heron Therapeutics, Inc. /DE/: frequently asked questions
Is Heron Therapeutics, Inc. /DE/ an American company?
Heron Therapeutics, Inc. /DE/ is a US-based company headquartered in San Diego, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Heron Therapeutics, Inc. /DE/ headquartered?
Heron Therapeutics, Inc. /DE/ is headquartered in San Diego, California, United States.
Is Heron Therapeutics, Inc. /DE/ publicly traded?
Yes — Heron Therapeutics, Inc. /DE/ is a publicly traded company. Its stock trades under the ticker symbol HRTX on the NASDAQ.
What does Heron Therapeutics, Inc. /DE/ do?
Heron Therapeutics, Inc. /DE/ is an American Pharmaceuticals company in the Health & Beauty sector.
